title: Copy number polymorphisms and anticancer pharmacogenomics.
abstract: BACKGROUND
  Recent studies have investigated the contribution of copy number variants (CNVs) to disease susceptibility in a multitude of complex disorders, including systemic lupus erythematosus, Crohn's disease, and various neurodevelopmental disorders. Relatively few CNV studies, however, have been conducted on pharmacologic phenotypes even though these structural variants are likely to play an important role. We developed a genome-wide method to identify CNVs that contribute to heterogeneity in drug response, focusing on drugs that are widely used in anticancer treatment regimens.
  
  
  RESULTS
  We conducted a comprehensive genome-wide study of CNVs from population-scale array-based and sequencing-based surveys by analyzing their effect on cellular sensitivity to platinating agents and topoisomerase II inhibitors. We identified extensive CNV regions associated with cellular sensitivity to functionally diverse chemotherapeutics, supporting the hypothesis that variation in copy number contributes to variation in drug response. Interestingly, although single nucleotide polymorphisms (SNPs) tag some of the CNVs associated with drug sensitivity, several of the most significant CNV-drug associations are independent of SNPs; consequently, they represent genetic variations that have not been previously interrogated by SNP studies of pharmacologic phenotypes.
  
  
  CONCLUSIONS
  Our findings demonstrate that pharmacogenomic studies may greatly benefit from the study of CNVs as expression quantitative trait loci, thus contributing broadly to our understanding of the complex traits genetics of CNVs. We also extend our PACdb resource, a database that makes available to the scientific community relationships between genetic variation, gene expression, and sensitivity to various drugs in cell-based models.
authors: Section of Genetic Medicine, Department of Medicine, University of Chicago, 900 East 57th Street, Chicago, IL 60637, USA.
authors: Eric R
authors: ER
authors: Gamazon
authors: R Stephanie
authors: RS
authors: Huang
authors: M Eileen
authors: ME
authors: Dolan
authors: Nancy J
authors: NJ
authors: Cox
references: Nature. 2010 Apr 1;464(7289):704-12
references: 19812545
references: N Engl J Med. 2004 Dec 30;351(27):2827-31
references: 15625333
references: Nature. 2004 Aug 12;430(7001):743-7
references: 15269782
references: Clin Pharmacol Ther. 2005 Mar;77(3):145-58
references: 15735609
references: Leuk Res. 2008 Jun;32(6):919-29
references: 18207572
references: Cancer. 1993 Apr 1;71(7):2204-9
references: 8095847
references: Cancer Res. 2004 Jun 15;64(12):4353-6
references: 15205351
references: PLoS Genet. 2011 Feb 03;7(2):e1001292
references: 21304891
references: CA Cancer J Clin. 2009 Jan-Feb;59(1):42-55
references: 19147868
references: Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9758-63
references: 17537913
references: Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9440-5
references: 12883005
references: Eur J Cancer. 2007 Jan;43(2):283-90
references: 17084623
references: Cytogenet Genome Res. 2008;123(1-4):205-10
references: 19287157
references: Nature. 2010 Apr 1;464(7289):713-20
references: 20360734
references: Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):811-21
references: 20200426
references: Nat Genet. 2008 Oct;40(10):1166-74
references: 18776908
references: Mol Cancer Ther. 2008 Sep;7(9):3038-46
references: 18765826
references: Bioinformatics. 2010 Jan 15;26(2):259-62
references: 19933162
references: Science. 2005 Mar 4;307(5714):1434-40
references: 15637236
references: Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11825-9
references: 7903454
references: Cancer Res. 2008 May 1;68(9):3161-8
references: 18451141
references: Nat Genet. 2008 Sep;40(9):1107-12
references: 19165925
references: Nature. 2011 Feb 3;470(7332):59-65
references: 21293372
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: Breast Cancer Res Treat. 2007 Jan;101(1):113-21
references: 17115111
references: Nat Genet. 2003 Mar;33(3):422-5
references: 12567189
references: Proc Natl Acad Sci U S A. 2010 May 18;107(20):9287-92
references: 20442332
references: Pharmacol Rev. 2009 Dec;61(4):413-29
references: 20038569
references: Am J Hum Genet. 2008 May;82(5):1101-13
references: 18439551
references: Clin Cancer Res. 2004 May 1;10(9):3029-34
references: 15131039
references: Am J Hum Genet. 2007 Sep;81(3):427-37
references: 17701890
references: Nature. 2006 Nov 23;444(7118):444-54
references: 17122850
references: Pharmacogenet Genomics. 2010 Apr;20(4):269-73
references: 20216476